https://www.biopharmadive.com/news/roche-abbvie-venclexta-acute-myeloid-leukemia/574680/
Leukemia drug from Roche, AbbVie extends survival, study finds | BioPharma Dive
Paired with chemotherapy, Venclexta succeeded in a Phase 3 acute myeloid leukemia trial just weeks after falling short in another combination study.
leukemia drugextends survival
https://www.statnews.com/2025/12/06/ash-meeting-syndax-drug-for-acute-myeloid-leukemia/
'Remarkable' drug results against an aggressive leukemia | STAT
Dec 6, 2025 - At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, Von Willebrand disease and more.
remarkabledrugresultsleukemia
https://www.statnews.com/2025/12/08/terns-leukemia-drug-ash-results-tern-701/
Tern leukemia drug results likely to catch investor attention | STAT
leukemia drugternresultscatch
https://www.academia.edu/143352161/Celastrol_and_an_EGCG_pro_drug_exhibit_potent_chemosensitizing_activity_in_human_leukemia_cells
(PDF) Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia...
Aug 9, 2025 - Chemotherapy remains the staple of treatment for many types of leukemia. Despite the positive impact on extending overall survival in patients with...
pdfprodrugexhibitpotent